UTERINE_CERVIX_THP

Description: |
Stores single response data for College of American Pathologists (CAP) form field 76063-UTERINE CERVIX: Trachelectomy, Hysterectomy, Pelvic Exenteration.

Primary Key

Column Name | Ordinal Position |
--- | --- | ---
RESULT_ID | 1 |

Column Information

| Name | Type | Discontinued? |
--- | --- | --- | --- | ---
1 | RESULT_ID | VARCHAR | No |
The unique identifier for the result record.
2 | TUMOR_SITE_SPECIFY | VARCHAR | No |
CAP synoptic form item: Specify tumor site.
3 | CAP_COMMENTS | VARCHAR | No |
CAP synoptic form item: General comments.
4 | TUMOR_SIZE_GREAT | NUMERIC | No |
CAP synoptic form item: Tumor Greatest Size.
5 | TUMOR_SIZE_ADDL | NUMERIC | No |
CAP synoptic form item: Tumor Size (length).
6 | TUMOR_SIZE_ADDL2 | NUMERIC | No |
CAP synoptic form item: Tumor Size (width).
7 | TUMOR_SIZE_SPECIFY | VARCHAR | No |
CAP synoptic form item: Specify Tumor Size.
8 | SPECIMEN_OTHER_SPFY | VARCHAR | No |
CAP synoptic form item: Specify other specimen.
9 | REGIONL_LYMPH_ND_C_NAME | VARCHAR | No |
CAP synoptic form item: Regional Lymph Nodes (pN).
May contain organization-specific values: Yes
Category Entries:
pNX: Cannot be assessed
pN0: No regional lymph node metastasis
pN1: Regional lymph node metastasis
pN1: Metastasis in perirectal lymph nodes
pN1: Metastasis in 1 to 3 regional lymph nodes
pN1a: Metastasis in 1 regional lymph node
pN1b: Metastasis in 2 to 3 regional lymph nodes
pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta
pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes
pN1: Regional lymph node metastasis involving 1 to 2 nodes
pN1 (IIIC): Regional lymph node metastasis
pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery
pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes,
pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes
pN1a: Clinically occult (microscopic) metastasis
pN1b: Clinically apparent (macroscopic) metastasis
pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension
pN1: Metastasis in 1 to 2 perigastric lymph nodes
pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension,
pN1a: Nodal metastases to Level VI lymph nodes
pN1b: Metastases to unilateral, bilateral or contralateral cervical
pN1: Single regional lymph node metastasis in the true pelvis
pN1 (IVB): Pelvic or inguinal lymph node metastasis
pN1: Metastasis in regional lymph node or nodes
pN1: Regional lymph node involvement (preauricular, cervical, submandibular)
pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s)
pN2: Metastasis in 4 or more regional lymph nodes
pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd
pN2a: Metastasis in 4 to 6 regional lymph nodes
pN2b: Metastasis in 7 or more regional lymph nodes
pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho
pN2: 3 to 6 nodes involved
pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than
pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen.
pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s)
pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes
pN2a: Clinically occult (microscopic) metastasis
pN2b: Clinically apparent (macroscopic) metastasis
pN2c: Satellite or in-transit metastasis without nodal metastasis
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension
pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than
pN2: Metastasis in 3 to 6 perigastric lymph nodes
pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm
pN2: Multiple regional lymph node metastasis in the true pelvis
pN2: Distant lymph node involvement
pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il
pN3: 7 or more nodes involved
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or
pN3: Metastases in the contralateral mediastinal, contralateral internal mammary,
pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or
pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa
pN3a: Greater than 6 cm in dimension
pN3b: Extension to the supraclavicular fossa
pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension
pN3: Metastasis in 7 or more perigastric lymph nodes
pN3a: Metastasis in 7 to 15 perigastric lymph nodes
pN3b: Metastasis in 16 or more perigastric lymph nodes
pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension
pN3: Lymph node metastasis to the common iliac lymph nodes
pN1: One or two regional lymph nodes with the following features
pN2 (FIGO IIIB): Regional lymph node metastasis with the following features
pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis
10 | PRIMARY_TUMOR_C_NAME | VARCHAR | No |
CAP synoptic form item: Primary Tumor (pT).
May contain organization-specific values: Yes
Category Entries:
pTX: Cannot be determined
pTX: Cannot be assessed, or tumor proven by presence of malignant cells in sputum or
pTX: Cannot be assessed
pT0: No evidence of primary tumor
pTis: Carcinoma in situ
pTis (DCIS): Ductal carcinoma in situ
pTis (LCIS): Lobular carcinoma in situ
pTis (Paget): Paget disease of the nipple NOT associated with invasive carcinoma and
pTis: Carcinoma in situ, intraepithelial (no invasion)
pTis: Carcinoma in situ, invasion of lamina propria
pTis: High-grade dysplasia / carcinoma in situ
pTis: Tubal intraepithelial carcinoma (limited to tubal mucosa)
pTis: Melanoma in situ (i.e., not an invasive tumor: anatomic level I)
Encapsulated
Extracapsular extension without adjacent organ involvement
Extension into adjacent organs
Extension into spinal canal
pTa: Papillary noninvasive carcinoma
pTa: Noninvasive papillary carcinoma
pTis: Intratubular germ cell neoplasia only (carcinoma in situ)
pTis: Flat carcinoma in situ
pTis: Carcinoma in situ: flat tumor
Iris
Ciliary Body and Choroid
pT1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion
pT1: Tumor limited to ampulla of Vater or sphincter of Oddi
pT1: Tumor 2 cm or less in greatest dimension
pT1: Tumor invades submucosa
pT1: Tumor confined to the bile duct histologically
pT1: Solitary tumor without vascular invasion
pT1: Tmr confined to bile duct, w/ extension up to muscle layer or fibrous tissue
pT1: Tumor 8 cm or less in greatest dimension
pT1mi: Tumor <= 1 mm in greatest dimension (microinvasion)
pT1a: Tumor > 1 mm but <= 5 mm in greatest dimension
pT1b: Tumor > 5 mm but <= 10 mm in greatest dimension
pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension
pT1a (IA): Tumor limited to endometrium or invades less than one-half of myometrium
pT1b (IB): Tumor invades greater than or equal to one-half of the myometrium
pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
pT1a: Tumor invades lamina propria or muscularis mucosae
pT1a: Tumor invades lamina propria
pT1 (I): Tumor limited to fallopian tube(s)
pT1a (IA): Tumor limited to 1 tube without penetrating serosal surface; no ascites
pT1b (IB): Tumor limited to both tubes w/o penetrating serosal surface; no ascites
pT1c (IC): Tmr limited to 1 or both tube(s) w/ extension into or through tubal serosa
pT1b: Tumor invades submucosa
pT1b: Tumor invades muscle layer
pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney
pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney
pT1b: Tumor > 4cm but not more than 7cm in greatest dimension, limited to kidney
pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura
pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by
pT1: Tumor <=2cm in greatest dimension (without extraparenchymal extension) (Note I)
pT1a: Tumor limited to ipsilateral parietal pleura with or without mediastinal or
pT1b: Tumor involves ipsilateral parietal pleura with or without mediastinal or
pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses / mm*mm
pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1+ mitoses/mm*mm
pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. N
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface
pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule
pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimen
pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal
pT1: Tmr limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimen
pT1: Tumor invades subepithelial connective tissue (lamina propria)
pT1: Tumor confined to the eye with no optic nerve or choroidal invasion
pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor
pT1b: Tumor 5 cm or less in greatest dimension, deep tumor
pT1: Tumor 2 cm or less in greatest dimension with less than two high risk features
pT1: Tumor limited to the testis and epididymis without vascular / lymphatic invasion
pT1: Tumor size 2 cm or less, limited to thyroid
pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid
pT1b: Tmr more than 1 cm but not more than 2cm in greatest dimen., limited to thyroid
pT1 (I): Tumor confined to uterus
pT1a (IA): Invasive carcinoma diagnosed by microscopy only. All macroscopically
pT1a1 (IA1): Stromal invasion 3.0mm or less in depth, horizontal spread 7.0mm or less
pT1a2 (IA2): Stromal invasion more than 3.0 mm but not more than 5.0 mm in depth
pT1b (IB): Clinically visible lesion confined to cervix/microscopic lesion > T1a2/IA2
pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension
pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension
pT1 (I): Tumor confined to vaginal wall
pT1a (FIGO IA): Lesions 2 cm or less in size, confined to the vulva or perineum
pT1b (FIGO IB): Lesions more than 2 cm in size or any size with stromal invasion more
pT2: Tumor greater than 5 cm, no extra-adrenal invasion
pT2: Tumor invades duodenal wall
pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension
pT2: Tumor invades muscularis propria
pT2: Tumor invades beyond the wall of the bile duct
pT2a: Solitary tumor with vascular invasion
pT2b: Multiple tumors, with or without vascular invasion
pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue
pT2b: Tumor invades adjacent hepatic parenchyma
pT2: Tumor more than 8 cm in greatest dimension
pT2: Tumor > 20 mm but <= 50 mm in greatest dimension
pT2 (II): Tumor invades stromal connective tissue of the cervix, but does not extend
pT2 (II): Tumor involves 1 or both tube(s) with pelvic extension
pT2a (IIA): Extension and / or metastasis to the uterus and / or ovaries
pT2b (IIB): Extension to other pelvic structures
pT2c (IIC): Pelvic extension (T2a,T2b/IIA or IIB) w/ malignant cells in ascites
pT2: Tmr invades perimuscular connective tissue; no extension beyond serosa/in liver
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney
pT2a: Tumor more than 7 cm but >= 10 cm in greatest dimension, limited to kidney
pT2b: Tumor more than 10 cm, limited to the kidney
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by l
pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension
pT2: Tumor >2cm but <=4cm in greatest dimension (without extraparenchymal extension)
pT2: Tumor involves each of the ipsilateral pleural surfaces (parietal, mediastinal,
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
pT2a (IIA): Extension and / or implants on uterus and / or tube(s). No malignant cell
pT2b (IIB): Extension to other pelvic tissues. No malignant cells in ascites or
pT2c (IIC): Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than
pT2: Tumor with parapharyngeal extension
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or
pT2: Organ confined
pT2a: Unilateral, involving one-half of 1 side or less
pT2b: Unilateral, involving more than one-half of 1 side but not both sides
pT2c: Bilateral disease
pT2a: Tmr invades optic nerve head no extend past lamina or focal choroidal invasion
pT2b: Tmr invades optic nerve head no extend past lamina and focal choroidal invasion
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor
pT2: Tumor greater than 2 cm in greatest dimension with or without one additional
pT2: Tumor limited to the testis and epididymis with vascular / lymphatic invasion
pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid
pT2 (II): Tumor extends outside of the uterus but is limited to genital structures
pT2a: Tumor invades superficial muscularis propria (inner half)
pT2b: Tumor invades deep muscularis propria (outer half)
pT2a (IIA): Tumor without parametrial invasion
pT2a1 (IIA1): Clinically visible lesion less than or equal to 4.0cm in greatest dimen
pT2a2 (IIA2): Clinically visible lesion greater than 4.0 cm in greatest dimension
pT2b (IIB): Tumor with parametrial invasion
pT2 (II): Tumor invades paravaginal tissues but not the pelvic wall
pT2 (FIGO II): Tumor of any size with extension to adjacent perineal structures
pT3: Tumor of any size with local invasion, but not invading adjacent organs
pT3: Tumor invades pancreas
pT3: Tumor more than 5 cm in greatest dimension
pT3: Tumor invades through the muscularis propria into the subserosa or mesoappendix
pT3: Tmr invades gallbladder,pancreas,duodenum,other adj. organs w/o involvement of
pT3: Tmr perforates visc. peritoneum/invol local extrahepatic struct. by direct invas
pT3: Tumor invades unilateral branches of the portal vein or hepatic artery
pT3: Discontinuous tumors in primary bone site (not including skip metastases)
pT3: Tumor > 50 mm in greatest dimension
pT3: Tumor invades through the muscularis propria into pericolorectal tissues
pT3a (IIIA): Tumor involves serosa and / or adnexa (direct extension or metastasis)
pT3b (IIIB): Vaginal involvement (direct extension/metastasis) or parametrial involve
pT3: Tumor invades adventitia
pT3/N1 (III): Tmr involves 1 or both tube(s) with peritoneal implants outside pelvis
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2cm in greatest dimen
pT3c / NI (IIIC): Peritoneal metastasis beyond pelvis >2cm in greatest dimen
pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver
pT3a: Multiple tumors more than 5 cm
pT3b: Single/multiple tmrs any size involving major branch of portal/hepatic veins
pT3: Tmr extends into major veins/perinephric tissues, not into ipsilateral adrenal
pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing)
pT3b: Tumor grossly extends into the vena cava below the diaphragm
pT3c: Tmr grossly extends into vena cava above diaphragm or invades wall of vena cava
pT3: Mucosal disease
pT3: Tumor more than 4 cm in greatest dimension
pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that
pT3: Tumor more than 4 cm and / or tumor (having extraparenchymal extension) (Note I)
pT3: Locally advanced but potentially resectable tumor that involves all of the
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)
pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis <=2 cm in greatest dimen
pT3c and / or N1 (IIIC): Peritoneal metastasis beyond pelvis >2 cm in greatest dimen
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or
pT3: Tmr >4 cm in greatest dimension/extension to lingual surface of epiglottis
pT3: Tumor invades bony structures of skull base and / or paranasal sinuses
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilary
pT3a: Extraprostatic extension or microscopic invasion of bladder neck
pT3b: Seminal vesicle invasion
pT3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma
pT3a: Tumor invades optic nerve past lamina cribrosa OR focal choroidal invasion
pT3b: Tumor invades optic nerve past lamina cribrosa AND focal choroidal invasion
pT3: Tumor invades through the muscularis propria into the subserosa or into the
pT3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone
pT3: Tumor invades subserosal connective tissue, without involvement of
pT3: Tumor invades spermatic cord with or without vascular / lymphatic invasion
pT3: Tumor >4 cm limited to thyroid or any tumor with minimal extrathyroid extension
pT3: Tumor invades beyond muscularis propria into periureteric fat
pT3a: Microscopically
pT3b: Macroscopically (extravesicular mass)
pT3a (IIIA): Tumor involves lower third of vagina, but not pelvic wall
pT3b (IIIB): Tmr extend to pelvic wall and/or causes hydronephrosis/non-funct. kidney
pT3 (III): Tumor extends to pelvic wall
pT3 (FIGO IVA): Tumor of any size with extension to any of the following
pT4: Tumor of any size with invasion of adjacent organs
pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures
pT4: Tmr of any size w/ invasion of adjacent organ(s) e.g. vagina, urethra, bladder
pT4: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor within
pT4: Tumor involves the celiac axis or the superior mesenteric artery
pT4: Tumor with periductal invasion
pT4: Tumor invades main portal vein or its branches bilaterally; or the common hepati
pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa
pT4: Tumor invades adjacent structures
pT4: Tumor invades main portal vein or hepatic artery or invades 2+ extrahepatic
pT4: Tmr w/ direct invasion of adj. organs other than gallbladder
pT4: Tmr invades beyond Gerota’s fascia
pT4: Tumor of any size that invades any of the following: mediastinum, heart, great
pT4: Locally advanced technically unresectable tumor involving all of the ipsilateral
pT4: Tumor with intracranial extension and / or involvement of cranial nerves,
pT4: Invasion of rectum, levator muscles, and / or pelvic wall (Note J)
pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat
pT4a: Tmr invades optic nerve to resection line, no extra-ocular extension identified
pT4b: Tumor invades optic nerve to resection line, extra-ocular extension identified
pT4: Tumor with direct or perineural invasion of skull base or axial skeleton
pT4: Tmr involves visc. peritoneum (serosal surf.) or directly invades adj. structure
pT4: Tumor invades scrotum with or without vascular / lymphatic invasion
pT4: Tumor invades adjacent organs
pT4 (IVA): Tmr invades the mucosa of bladder/rectum and/or extends beyond true pelvis
pT4 (IVA): Tmr invades mucosa of bladder or rectum and/or extends beyond true pelvis
pT4a: Tumor penetrates visceral peritoneum, including mucinous peritoneal tumor withi
pT4a: Tumor penetrates the visceral peritoneum
pT4a: Extension to chest wall, not including only pectoralis muscle adherence / invas
pT4b: Ulceration/ipsilateral satellite nodules/edema of skin which dont meet criteria
pT4c: Both T4a and T4b
pT4d: Inflammatory carcinoma
pT4b: Tumor directly invades other organs or structures
pT4b: Tumor directly invades or is adherent to other organs or structures
pT4a: Resectable tumor invading pleura, pericardium, or diaphragm
pT4b: Unresectable tmr invading other adj. structures, such as aorta, vertebral body
Any T / Any N and M1 (IV): Distant metastasis including presence of malignant cells
Primary Tumor (pT): Supraglottis
Primary Tumor (pT): Glottis
Primary Tumor (pT): Subglottis
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone,
pT4b: Very advanced disease. Tumor involving brain, dura, skull base,
pT4a: Moderately advanced local disease.
pT4b: Very advanced local disease.
pT4a: Moderately advanced local disease. Tumor invades skin, mandible, ear canal,
pT4b: Very advanced local disease. Tumor invades skull base and / or pterygoid plates
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
Primary Tumor (pT): Maxillary Sinus
Primary Tumor (pT): Nasal Cavity and Ethmoid Sinus
pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic
pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid
pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage,
pT4b: Very advanced local disease. Tumor invades prevertebral fascia, encases
pT4a: Tumor involves visceral peritoneum (serosal surface)
pT4b: Tumor directly invades adjacent structures
pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid
pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid
pT4a: Intrathyroidal anaplastic carcinoma-surgically resectable
pT4b: Extrathyroidal anaplastic carcinoma-surgically unresectable
pT4a: Tumor invades prostatic stroma or uterus or vagina
pT4b: Tumor invades pelvic wall or abdominal wall
Not identified
11 | DISTNT_METASTASIS_C_NAME | VARCHAR | No |
CAP synoptic form item: Distant Metastasis.
May contain organization-specific values: Yes
Category Entries:
Not applicable
cM0 (i+): No clinical or radiographic evidence of distant metastasis
pM0: No distant metastasis
pM1: Distant metastasis
pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx
pM1b: Nonperitoneal metastasis
pM1: Distant detectable metastasis as determined by classic clinical
pM1 (IVB): Distant metastasis
pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or
pM1b: Distant metastases outside the lung / pleura
pM1: Distant metastasis (documented in this specimen)
pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes
pM1b: Metastasis to lung
pM1c: Metastasis to all other visceral sites or distant metastasis at any site
pM1a: Nonregional lymph node(s)
pM1b: Bone(s)
pM1c: Other site(s) with or without bone disease
pM1: Metastasis to sites other than CNS
pM1a: Single lesion
pM1b: Multiple lesions
pM1c: CNS metastasis
pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement
pM1e: Leptomeningeal and / or CSF involvement
pM1a: Non-regional lymph nodes or pulmonary metastasis
pM1b: Distant metastasis other than to nonregional lymph nodes and lungs
pM1a (III): Tumor extends to the lungs with or without genital tract involvement
pM1b (IV): Tumor involves other metastatic sites
pM1a: Largest diameter of the largest metastasis 3 cm or less
pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm
pM1c: Largest diameter of the largest metastasis 8 cm or more
pM1a: Lung
pM1b: Metastasis involving distant sites other than lung (including skip metastases)
Distant Metastasis present (includes metastasis to lymph nodes)
12 | ADDL_PATH_FIND_SPFY | VARCHAR | No |
CAP synoptic form item: Specify additional pathologic findings.
13 | HISTOLOGIC_GRADE_C_NAME | VARCHAR | No |
CAP synoptic form item: Histologic Grade.
May contain organization-specific values: Yes
Category Entries:
Not applicable
GX: Cannot be assessed
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
G4: Undifferentiated
G4: Undifferentiated / anaplastic
WHO grade not assigned
Low-grade (well-differentiated to moderately differentiated)
High-grade (poorly differentiated to undifferentiated)
FIGO Grade 1
FIGO Grade 2
FIGO Grade 3
Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in
Less favorable (all subtypes other than those designated "Favorable" or "Unfavorable"
Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo
Gleason Pattern
Ungraded sarcoma
pGX: Grade cannot be assessed
pG1: Spindle cell melanoma
pG2: Mixed cell melanoma
pG3: Epithelioid cell melanoma
WHO Grade I
WHO Grade II
WHO Grade III
WHO Grade IV
pG1: Well differentiated
pG2: Moderately differentiated
pG3: Poorly differentiated
pG4: Undifferentiated
FNCLCC Grade 1
FNCLCC Grade 2
FNCLCC Grade 3
Grade 1
Grade 2
Grade 3
Cannot be determined
Other
14 | HIST_TYP_NONCL_SPFY | VARCHAR | No |
CAP synoptic form item: Specify other or nonclassifiable histologic type.
15 | HIST_TP_SQUA_CCNM_S | VARCHAR | No |
CAP synoptic form item: Specify details for Histologic Type Squamous cell carcinoma.
16 | HIST_TP_ADCCNM_OS | VARCHAR | No |
CAP synoptic form item: Specify other details for Histologic Type Adenocarcinoma.
17 | ADF_ITAPTLL_NPLS_S | VARCHAR | No |
CAP synoptic form item: Specify type and grade for Intraepithelial neoplasia in Additional Pathologic Findings section.
18 | MG_UVLV_IC_DSTNC_IC | NUMERIC | No |
CAP synoptic form item: Margins uninvolved by invasive carcinoma - Distance of Invasive Carcinoma from Closest Margin.
19 | MG_UVLV_IC_SM | VARCHAR | No |
CAP synoptic form item: Specify Margin for Margins uninvolved by invasive carcinoma.
20 | MGN_UVLV_IVS_CCNM_C_NAME | VARCHAR | No |
CAP synoptic form item: Margins uninvolved by invasive carcinoma.
May contain organization-specific values: Yes
Category Entries:
Carcinoma in situ not identified at distal margin
Carcinoma in situ present at distal margin
Dysplasia / carcinoma in situ not identified at margin
Dysplasia / carcinoma in situ present at margin
21 | MGN_IVLV_IVS_CCNM_S | VARCHAR | No |
CAP synoptic form item: Specify details for Margin Involvement by Invasive Carcinoma.
22 | ANCLR_STD_SPEC | VARCHAR | No |
CAP synoptic form item: Specify details for ancillary studies.
23 | PN1_RGNL_LNM_NUM_XM | VARCHAR | No |
CAP synoptic form item: Specify number examined for Regional Lymph Nodes (pN) pN1 Regional lymph node metastasis.
24 | PN1_RGNL_LNM_NUM_IV | VARCHAR | No |
CAP synoptic form item: Specify number involved for Regional Lymph Nodes (pN) pN1 Regional lymph node metastasis.
25 | DSTNT_MTSTS_PM1_ST | VARCHAR | No |
CAP synoptic form item: Specify Site for Distant Metastases pM pM1 IVB Distant metastasis.
26 | SPEC_PROC_SPECIFY | VARCHAR | No |
CAP synoptic form item: Specify the Specimen Procedure.